Diagnostic and Immunologic Testing for Varicella in the Era of High-Impact Varicella Vaccination: An Evolving Problem
Open Access
- 21 October 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 226 (Supplement) , S450-S455
Abstract
The clinical presentation of varicella in unvaccinated persons, with skin vesicles and scabs, has facilitated the use of rapid diagnostic methods for confirming disease. Polymerase chain reaction (PCR) assays are the diagnostic method of choice. The sharp decline in unmodified cases of varicella due to the US varicella vaccination program has led to fewer healthcare providers being familiar with varicella presentation and an increased reliance on laboratory diagnosis to confirm suspected cases. The mild, atypical presentation of the disease in vaccinated persons (fewer skin lesions, mostly maculopapular) has made it more challenging for providers to recognize and also to collect samples to detect the virus. Nonetheless, PCR is highly sensitive and specific in confirming modified disease if adequate samples are provided. While a positive PCR result is confirmatory, interpreting a negative result can prove to be more challenging in determining whether suspected varicella is falsely negative or attributable to other causes. Enhanced education of healthcare providers is critical for adequate specimen collection from modified varicella cases. In addition, more sensitive commercial serologic assays are needed in the United States for varicella immunity testing in the vaccine era.Keywords
This publication has 39 references indexed in Scilit:
- Should Varicella-Zoster Virus Culture Be Eliminated? A Comparison of Direct Immunofluorescence Antigen Detection, Culture, and PCR, with a Historical ReviewJournal of Clinical Microbiology, 2012
- Evaluation of Three Commercial Varicella-Zoster Virus IgG Enzyme-Linked Immunosorbent Assays in Comparison to the Fluorescent-Antibody-to-Membrane-Antigen TestClinical and Vaccine Immunology, 2012
- Novel Genetic Variation Identified at Fixed Loci in ORF62 of the Oka Varicella Vaccine and in a Case of Vaccine-Associated Herpes ZosterJournal of Clinical Microbiology, 2012
- Molecular Analysis of Varicella Vaccines and Varicella-Zoster Virus from Vaccine-Related Skin LesionsClinical and Vaccine Immunology, 2011
- Varicella Zoster Disease of the Central Nervous System: Epidemiological, Clinical, and Laboratory Features 10 Years after the Introduction of the Varicella VaccineThe Journal of Infectious Diseases, 2011
- Impact of Varicella Vaccine on Varicella-Zoster Virus DynamicsClinical Microbiology Reviews, 2010
- Primary Vaccine Failure after 1 Dose of Varicella Vaccine in Healthy ChildrenThe Journal of Infectious Diseases, 2008
- Genotyping of Varicella-Zoster Virus and the Discrimination of Oka Vaccine Strains by TaqMan Real-Time PCRJournal of Clinical Microbiology, 2006
- Comparison of MRC-5 and A-549 cells in conventional culture tubes and shell vial assays for the detection of varicella-zoster virusDiagnostic Microbiology and Infectious Disease, 1993
- Detection of antibody to varicella‐zoster virus by competitive and IgM‐antibody capture immunoassayJournal of Medical Virology, 1981